Zobrazeno 1 - 10
of 12
pro vyhledávání: '"Vinod Kolimarala"'
Publikováno v:
Case Reports in Pediatrics, Vol 2017 (2017)
Serology is frequently used for the diagnosis of coeliac disease in children; however, a small proportion of children are seronegative. We present a case of seronegative coeliac disease along with literature review to include diagnostic and managemen
Externí odkaz:
https://doaj.org/article/1e2917cca63c46dd83e15f6ba9d2abc4
Autor:
Christopher Roberts, Maryam Hussein, Esme Poole, Vinod Kolimarala, Mich Erlewyn-Lajeunesse, R. Mark Beattie, Francis Sundrum, Nadeem Afzal
Publikováno v:
Journal of Pediatric Gastroenterology & Nutrition. 76:428-433
Autor:
Nicola McCallion, Carin Swart, Hermione Race, Sheriyar Khan, Rohit Gowda, Bim Bhaduri, Vinod Kolimarala
Publikováno v:
Posters.
Publikováno v:
Paediatrics and Child Health. 29:377-383
Publikováno v:
Poster presentations.
Introduction In the past 10 years faecal calprotectin has been increasingly used in Paediatrics, as in adults, to screen for inflammatory bowel disease (IBD). Faecal calprotectin is a calcium and zinc binding protein expressed by neutrophils and can
Publikováno v:
Poster presentations.
Introduction/Background Intestinal strictures are a complication of Crohn’s disease despite optimal medical management. Endoscopic balloon dilatation is frequently used for management of simple strictures in adults in comparison to the paediatric p
Autor:
Nicola McCallion, Carin Swart, Hermione Race, Sheriyar Khan, Rohit Gowda, Bim Bhaduri, Vinod Kolimarala
Publikováno v:
Gastroenterology. 162:S-846
Autor:
Zinia Abid, Catherine Taylor, Louise Fuentes, Carin Swart, Rohit Gowda, Sheriyar Khan, Hermione Race, Bim Bhaduri, Vinod Kolimarala
Publikováno v:
Gastroenterology. 162:S-292
Introduction: Long-term, sustained, remission is the ultimate goal of contemporary inflammatory bowel disease (IBD) therapy. Avoiding complications, surgery and malignancy, alongside minimizing the side effects of medications are vital. However, the
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::1ffb06eea993a763f7720c7cfbac4533
https://eprints.soton.ac.uk/436418/
https://eprints.soton.ac.uk/436418/
Autor:
Vinod Kolimarala, Nikolaos K. Kanakaris, Richard J. Montgomery, Rozalia Dimitriou, Peter V. Giannoudis, Ian Gill
Publikováno v:
Clinical Orthopaedics and Related Research®. 467:3239-3248
Combining autologous bone graft and recombinant human bone morphogenetic protein-7 (BMP-7) to treat long-bone fracture aseptic atrophic nonunions theoretically could promote bone healing at higher rates than each of these grafting agents separately.